COMPOUND PROFILE / PROTEINS & BIOLOGICS
sh-Oligopeptide-1 / recombinant EGF.
Research draftsh-Oligopeptide-1 is a cosmetic ingredient name associated with recombinant epidermal growth factor.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Identity and evidence review notes
Confirm exact identity, sequence, alias or formulation before attaching product-specific evidence.
Overview
sh-Oligopeptide-1 is a cosmetic ingredient name associated with recombinant epidermal growth factor.
Mechanism
Confirmed EGF activates growth-factor receptor signalling; ingredient name alone does not establish potency or purity.
Human research
Topical cosmetic and wound findings are formulation-specific and cannot validate systemic use.
Preclinical & other research
Cell research examines proliferation and repair-related signalling.
Safety & unknowns
Growth-factor activity and route differences prevent broad safety claims.
Regulatory status
Cosmetic availability is not injectable medicine approval; cross-link EGF only after identity matching.
Reported use & evidence
The supplied sh-Oligopeptide-1 / recombinant EGF profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.